Simon Metenou

1.2k total citations
29 papers, 925 citations indexed

About

Simon Metenou is a scholar working on Immunology, Infectious Diseases and Parasitology. According to data from OpenAlex, Simon Metenou has authored 29 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Infectious Diseases and 12 papers in Parasitology. Recurrent topics in Simon Metenou's work include Parasitic Diseases Research and Treatment (12 papers), Parasites and Host Interactions (12 papers) and Malaria Research and Control (6 papers). Simon Metenou is often cited by papers focused on Parasitic Diseases Research and Treatment (12 papers), Parasites and Host Interactions (12 papers) and Malaria Research and Control (6 papers). Simon Metenou collaborates with scholars based in United States, Mali and Cameroon. Simon Metenou's co-authors include Thomas B. Nutman, Diane Wallace Taylor, Rosette Megnekou, Josephine Fogako, Amorsolo L. Suguitan, Amy D. Klion, Ainong Zhou, Benoit Dembélé, Lucy Thuita and Yaya Ibrahim Coulibaly and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Simon Metenou

29 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Metenou United States 17 421 413 300 283 183 29 925
Sarah Joseph United Kingdom 13 293 0.7× 255 0.6× 196 0.7× 588 2.1× 118 0.6× 18 1.2k
Arlene E. Dent United States 21 217 0.5× 873 2.1× 160 0.5× 558 2.0× 22 0.1× 61 1.5k
Charles Mackenzie United States 15 353 0.8× 348 0.8× 497 1.7× 136 0.5× 215 1.2× 42 922
Issa Diarra Mali 13 254 0.6× 564 1.4× 86 0.3× 198 0.7× 114 0.6× 29 794
A. Raiko Papua New Guinea 13 321 0.8× 276 0.7× 82 0.3× 95 0.3× 201 1.1× 18 650
Jonathan D. Kurtis United States 23 955 2.3× 309 0.7× 98 0.3× 58 0.2× 450 2.5× 46 1.3k
P Jourdan Norway 13 804 1.9× 154 0.4× 145 0.5× 155 0.5× 363 2.0× 20 1.2k
Caroline Othoro United States 13 105 0.2× 443 1.1× 62 0.2× 369 1.3× 18 0.1× 15 708
Blanca Jarilla Philippines 14 478 1.1× 152 0.4× 55 0.2× 51 0.2× 258 1.4× 33 651
George L. Freeman United States 16 586 1.4× 288 0.7× 75 0.3× 122 0.4× 211 1.2× 29 744

Countries citing papers authored by Simon Metenou

Since Specialization
Citations

This map shows the geographic impact of Simon Metenou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Metenou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Metenou more than expected).

Fields of papers citing papers by Simon Metenou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Metenou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Metenou. The network helps show where Simon Metenou may publish in the future.

Co-authorship network of co-authors of Simon Metenou

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Metenou. A scholar is included among the top collaborators of Simon Metenou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Metenou. Simon Metenou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lakhani, Nehal J., Daphne Stewart, Debra L. Richardson, et al.. (2025). First-in-human phase I trial of the bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, SL-172154 in patients with platinum-resistant ovarian cancer. Journal for ImmunoTherapy of Cancer. 13(1). e010565–e010565. 5 indexed citations
3.
Lakhani, Nehal J., Daphne Stewart, Debra L. Richardson, et al.. (2023). Phase 1 dose escalation study of SL-172154 (SIRPα-Fc-CD40L) in platinum-resistant ovarian cancer.. Journal of Clinical Oncology. 41(16_suppl). 5544–5544. 7 indexed citations
4.
Lee, Maxwell, Simon Metenou, Douglas E. Brough, et al.. (2021). Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis. npj Vaccines. 6(1). 86–86. 9 indexed citations
5.
Metenou, Simon, et al.. (2020). HIV-1 subtype C transmitted founders modulate dendritic cell inflammatory responses. Retrovirology. 17(1). 17–17. 2 indexed citations
6.
Chan, Tim Hon Man, Simon Metenou, Carol Poortman, et al.. (2020). Abstract 6593: PRGN-3005 UltraCAR-T™: multigenic CAR-T cells generated using non-viral gene delivery and rapid manufacturing process for the treatment of ovarian cancer. Cancer Research. 80(16_Supplement). 6593–6593. 6 indexed citations
7.
Kwan, Jennifer, Amy E. Seitz, Michal Fried, et al.. (2018). Seroepidemiology of helminths and the association with severe malaria among infants and young children in Tanzania. PLoS neglected tropical diseases. 12(3). e0006345–e0006345. 9 indexed citations
10.
Metenou, Simon, Subash Babu, & Thomas B. Nutman. (2012). Impact of filarial infections on coincident intracellular pathogens. Current Opinion in HIV and AIDS. 7(3). 231–238. 44 indexed citations
11.
Dolo, Housséini, Yaya Ibrahim Coulibaly, Benoit Dembélé, et al.. (2012). Filariasis Attenuates Anemia and Proinflammatory Responses Associated with Clinical Malaria: A Matched Prospective Study in Children and Young Adults. PLoS neglected tropical diseases. 6(11). e1890–e1890. 45 indexed citations
12.
Metenou, Simon, Michael A. Kovacs, Benoit Dembélé, et al.. (2011). Interferon regulatory factor modulation underlies the bystander suppression of malaria antigen‐driven IL‐12 and IFN‐γ in filaria‐malaria co‐infection. European Journal of Immunology. 42(3). 641–650. 25 indexed citations
13.
Metenou, Simon, Benoit Dembélé, Siaka Konaté, et al.. (2009). Patent Filarial Infection Modulates Malaria-Specific Type 1 Cytokine Responses in an IL-10-Dependent Manner in a Filaria/Malaria-Coinfected Population. The Journal of Immunology. 183(2). 916–924. 58 indexed citations
14.
Metenou, Simon, Amorsolo L. Suguitan, Carole A. Long, Rose G. F. Leke, & Diane Wallace Taylor. (2007). Fetal Immune Responses to Plasmodium falciparum Antigens in a Malaria-Endemic Region of Cameroon. The Journal of Immunology. 178(5). 2770–2777. 37 indexed citations
15.
Metenou, Simon, et al.. (2005). Current status of malaria in pregnant women in Cameroon. 5(3). 25–34. 1 indexed citations
16.
Suguitan, Amorsolo L., Rose G. F. Leke, Genevieve G. Fouda, et al.. (2003). Changes in the Levels of Chemokines and Cytokines in the Placentas of Women withPlasmodium falciparumMalaria. The Journal of Infectious Diseases. 188(7). 1074–7082. 132 indexed citations
17.
Suguitan, Amorsolo L., Thu Anh Nguyen, Ainong Zhou, et al.. (2003). MALARIA-ASSOCIATED CYTOKINE CHANGES IN THE PLACENTA OF WOMEN WITH PRE-TERM DELIVERIES IN YAOUNDE, CAMEROON. American Journal of Tropical Medicine and Hygiene. 69(6). 574–581. 61 indexed citations
18.
Leke, Rose F. G., Robinson Enow Mbu, Josephine Fogako, et al.. (2002). Plasmodium falciparum Infection in Pregnant Cameroonian Women: An Assessment of Changes in the Placenta of Low Birth Weight Infants. 2(1). 203–212. 4 indexed citations
19.
Zhou, Ainong, Rosette Megnekou, Robert Leke, et al.. (2002). Prevalence of Plasmodium falciparum infection in pregnant Cameroonian women.. American Journal of Tropical Medicine and Hygiene. 67(6). 566–570. 22 indexed citations
20.
Leke, Rose F. G., Robinson Enow Mbu, Robert Leke, et al.. (1999). Detection of thePlasmodium falciparumAntigen Histidine-Rich Protein 2 in Blood of Pregnant Women: Implications for Diagnosing Placental Malaria. Journal of Clinical Microbiology. 37(9). 2992–2996. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026